Market Research Logo

Farm Animal Drugs Market Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Farm Animal Drugs Market Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

The global farm animal drugs market is expected to reflect a CAGR of 6.3% over the period starting from 2017 and forecasted till 2027 from the market value standpoint, to reach a value of US$ 23,150 Mn by 2027. This positive growth over these years can be attributed to a rapid rise in the demand for quality pharmaceuticals and food security that fuel the increased adoption of farm animal drugs.

North America is poised to grow at a healthy 7.1% CAGR in terms of market value over the forecast period, with the anti-infective product type segment dominating the market in this region

The anti-infective product type segment is expected to witness higher growth and this trend is anticipated to continue through the forecast period. The North America region seems favourable for the farm animal drugs market. The anti-infective segment is estimated to reach a value of over US$ 1500 Mn in 2017 to project a high CAGR of 8.9% till 2027, and reach a value of more than US$ 3500 Mn by 2027 end in the North America regional market. Whereas, the parasiticides segment is estimated to be valued a bit less than US$ 1100 Mn in 2017 to reach a market value higher than US$ 2100 Mn in 2027. This reflects a CAGR of 7.2% during the forecast period. Canada and the United States show a higher contribution to the growth of the farm animal drugs market and are the most lucrative markets with a 1.0 Market Share Index. Many key players such as Zoetis, Elanco Animal Health, Merck and Phibro Animal Health Corporation in the farm animal drugs market in North America are coming up with new developments considering the potential of this region in terms of growth per year.

The anti-infective segment by product type dominates the global farm animal drugs market throughout the forecasted timeline, becoming the most lucrative segment to reflect a market attractiveness index of more than 2.8. The market share of the anti-infective and parasiticides segment is estimated to be 35.5% and 24.5% of the global farm animal drugs market in 2017.

A number of factors are contributing to the growth of the farm animal drugs market on a global scale

The major factors impacting the growth of the global farm animal drugs market include a rising demand for fresh meat; a focus on animal health, which ensures their protection from various infectious diseases with the administration of several drugs; and pain administration, which is an important aspect in animal health. Moreover, high demand for proteins obtained from animals along with a rise in demand for horse meat especially in Eastern Europe is contributing to the growth of the global farm animal drugs market. In Eastern Europe, horse meat is a preferred choice and a viable substitute to cattle meat. The increase in livestock, for example in Brazil, poultry farming in Australia, as well as unfortunate events such as an outbreak of bird flu and avian influenza that need immediate drug administration together aid the growth in adoption of farm animal drugs, thereby impacting the global farm animal drugs market. Asia Pacific is also a major contributor to global market growth as more drugs are required in this region. APAC is known for its growing animal industry, which is affected by zillions of diseases that necessitate treatment – this in turn drives the farm animal drugs market in this region.The anti-infective segment by product type is expected to gain 393 BPS in its market share while the parasiticides segment will gain 61 basis points, owing to a rapid increase in drugs used to treat farm animals. Various factors, their relevance, and impact on the global farm animal drugs market are considered. Factors such as investments in anti-infectives, the rate of treatment of animals, the number of animals affected with diseases, research in drug development for the animal sector, growth of product portfolios of several key players, government regulations and spending etc., are slated to have a varied impact on the market. Out of these factors, the number of animals affected with diseases show highest impact followed by the rate of treatment of animals. The global farm animal drugs market reflects an incremental opportunity of US$ 10,563 Mn from 2017 till 2027 and an absolute dollar opportunity of US$ 765 Mn in 2018 over 2017.


1. Executive Summary
A gist of the report, highlighting the key takeaways
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
A definition of farm animal drugs, its associated products and related market taxonomy
2.1. Market Taxonomy
2.2. Market Definition
3. Farm Animal Drugs Market Opportunity Analysis
Tracking the market scenario, with key inferences drawn from historical data, current trends, and future prospects
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Key Regulation
3.4. Porter’s Five Force Analysis
4. North America Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in the U.S. and Canada
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1.U.S.
4.4.2.Canada
4.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
4.5.1.Anti-Infective
4.5.2.Parasiticides
4.5.2.1.Endo-parasiticides
4.5.2.2.Ecto-parasiticides
4.5.2.3.Endectocides
4.5.3.Anti-inflammatory
4.5.4.Anesthetics
4.5.5.Analgesics
4.5.6.Hormones and related product
4.5.7.Others
4.6. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
4.6.1.Anti-Infective
4.6.2.Parasiticides
4.6.2.1.Endo-parasiticides
4.6.2.2.Ecto-parasiticides
4.6.2.3.Endectocides
4.6.3.Anti-inflammatory
4.6.4.Anesthetics
4.6.5.Analgesics
4.6.6.Hormones and related product
4.6.7.Others
4.7. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
4.7.1.Livestock Animals
4.7.1.1.Ruminants
4.7.1.2.Swine
4.7.1.3.Poultry
4.7.2.Equine
4.8. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
4.8.1.Livestock Animals
4.8.1.1.Ruminants
4.8.1.2.Swine
4.8.1.3.Poultry
4.8.2.Equine
4.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
4.9.1.Oral
4.9.2.Parenteral
4.9.3.Topical
4.9.4.Others
4.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
4.10.1. Oral
4.10.2. Parenteral
4.10.3. Topical
4.10.4. Others
4.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
4.11.1. Veterinary Hospitals
4.11.2. Veterinary Clinics
4.11.3. Pharmacies and Drug Stores
4.11.4. Others
4.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
4.12.1. Veterinary Hospitals
4.12.2. Veterinary Clinics
4.12.3. Pharmacies and Drug Stores
4.12.4. Others
4.13.Drivers and Restraints: Impact Analysis
4.14.Market Attractiveness Analysis
4.14.1. By Country
4.14.2. By Product Type
4.14.3. By Animal Type
4.14.4. By Route of Administration
4.14.5. By Distribution Channel
4.15.Key Representative Market Participants
4.16.Market Presence (Intensity Map)
5. Western Europe Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in U.K, France, Germany, Italy, Spain, Nordic, Benelux, and rest of Western Europe
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
5.3.1. U.K.
5.3.2. France
5.3.3. Germany
5.3.4. Italy
5.3.5. Spain
5.3.6. Nordic Countries
5.3.7. BENELUX Countries
5.3.8. Rest of Western Europe
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. U.K.
5.4.2. France
5.4.3. Germany
5.4.4. Italy
5.4.5. Spain
5.4.6. Nordic Countries
5.4.7. BENELUX Countries
5.4.8. Rest of Western Europe
5.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
5.5.1.Anti-Infective
5.5.2.Parasiticides
5.5.2.1.Endo-parasiticides
5.5.2.2.Ecto-parasiticides
5.5.2.3.Endectocides
5.5.3.Anti-inflammatory
5.5.4.Anesthetics
5.5.5.Analgesics
5.5.6.Hormones and related product
5.5.7.Others
5.6. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
5.6.1.Anti-Infective
5.6.2.Parasiticides
5.6.2.1.Endo-parasiticides
5.6.2.2.Ecto-parasiticides
5.6.2.3.Endectocides
5.6.3.Anti-inflammatory
5.6.4.Anesthetics
5.6.5.Analgesics
5.6.6.Hormones and related product
5.6.7.Others
5.7. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
5.7.1.Livestock Animals
5.7.1.1.Ruminants
5.7.1.2.Swine
5.7.1.3.Poultry
5.7.2.Equine
5.8. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
5.8.1.Livestock Animals
5.8.1.1.Ruminants
5.8.1.2.Swine
5.8.1.3.Poultry
5.8.2.Equine
5.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
5.9.1.Oral
5.9.2.Parenteral
5.9.3.Topical
5.9.4.Others
5.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
5.10.1. Oral
5.10.2. Parenteral
5.10.3. Topical
5.10.4. Others
5.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
5.11.1. Veterinary Hospitals
5.11.2. Veterinary Clinics
5.11.3. Pharmacies and Drug Stores
5.11.4. Others
5.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
5.12.1. Veterinary Hospitals
5.12.2. Veterinary Clinics
5.12.3. Pharmacies and Drug Stores
5.12.4. Others
5.13.Drivers and Restraints: Impact Analysis
5.14.Market Attractiveness Analysis
5.14.1. By Country
5.14.2. By Product Type
5.14.3. By Animal Type
5.14.4. By Route of Administration
5.14.5. By Distribution Channel
5.15.Key Representative Market Participants
5.16.Market Presence (Intensity Map)
6. Eastern Europe Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in Russia, Poland, and rest of Eastern Europe
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
6.3.1. Russia
6.3.2. Poland
6.3.3. Rest of Eastern Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Russia
6.4.2. Poland
6.4.3. Rest of Eastern Europe
6.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
6.5.1.Anti-Infective
6.5.2.Parasiticides
6.5.2.1.Endo-parasiticides
6.5.2.2.Ecto-parasiticides
6.5.2.3.Endectocides
6.5.3.Anti-inflammatory
6.5.4.Anesthetics
6.5.5.Analgesics
6.5.6.Hormones and related product
6.5.7.Others
6.6. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
6.6.1.Anti-Infective
6.6.2.Parasiticides
6.6.2.1.Endo-parasiticides
6.6.2.2.Ecto-parasiticides
6.6.2.3.Endectocides
6.6.3.Anti-inflammatory
6.6.4.Anesthetics
6.6.5.Analgesics
6.6.6.Hormones and related product
6.6.7.Others
6.7. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
6.7.1.Livestock Animals
6.7.1.1.Ruminants
6.7.1.2.Swine
6.7.1.3.Poultry
6.7.2.Equine
6.8. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
6.8.1.Livestock Animals
6.8.1.1.Ruminants
6.8.1.2.Swine
6.8.1.3.Poultry
6.8.2.Equine
6.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
6.9.1.Oral
6.9.2.Parenteral
6.9.3.Topical
6.9.4.Others
6.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
6.10.1. Oral
6.10.2. Parenteral
6.10.3. Topical
6.10.4. Others
6.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
6.11.1. Veterinary Hospitals
6.11.2. Veterinary Clinics
6.11.3. Pharmacies and Drug Stores
6.11.4. Others
6.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
6.12.1. Veterinary Hospitals
6.12.2. Veterinary Clinics
6.12.3. Pharmacies and Drug Stores
6.12.4. Others
6.13.Drivers and Restraints: Impact Analysis
6.14.Market Attractiveness Analysis
6.14.1. By Country
6.14.2. By Product Type
6.14.3. By Animal Type
6.14.4. By Route of Administration
6.14.5. By Distribution Channel
6.15.Key Representative Market Participants
6.16.Market Presence (Intensity Map)
7. Latin America Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in Brazil, Mexico, Argentina and rest of Latin America
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
7.3.1. Brazil
7.3.2. Mexico
7.3.3. Argentina
7.3.4. Rest of Latin America
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Argentina
7.4.4. Rest of Latin America
7.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
7.5.1.Anti-Infective
7.5.2.Parasiticides
7.5.2.1.Endo-parasiticides
7.5.2.2.Ecto-parasiticides
7.5.2.3.Endectocides
7.5.3.Anti-inflammatory
7.5.4.Anesthetics
7.5.5.Analgesics
7.5.6.Hormones and related product
7.5.7.Others
7.6. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
7.6.1.Anti-Infective
7.6.2.Parasiticides
7.6.2.1.Endo-parasiticides
7.6.2.2.Ecto-parasiticides
7.6.2.3.Endectocides
7.6.3.Anti-inflammatory
7.6.4.Anesthetics
7.6.5.Analgesics
7.6.6.Hormones and related product
7.6.7.Others
7.7. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
7.7.1.Livestock Animals
7.7.1.1.Ruminants
7.7.1.2.Swine
7.7.1.3.Poultry
7.7.2.Equine
7.8. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
7.8.1.Livestock Animals
7.8.1.1.Ruminants
7.8.1.2.Swine
7.8.1.3.Poultry
7.8.2.Equine
7.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
7.9.1.Oral
7.9.2.Parenteral
7.9.3.Topical
7.9.4.Others
7.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
7.10.1. Oral
7.10.2. Parenteral
7.10.3. Topical
7.10.4. Others
7.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
7.11.1. Veterinary Hospitals
7.11.2. Veterinary Clinics
7.11.3. Pharmacies and Drug Stores
7.11.4. Others
7.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
7.12.1. Veterinary Hospitals
7.12.2. Veterinary Clinics
7.12.3. Pharmacies and Drug Stores
7.12.4. Others
7.13.Drivers and Restraints: Impact Analysis
7.14.Market Attractiveness Analysis
7.14.1. By Country
7.14.2. By Product Type
7.14.3. By Animal Type
7.14.4. By Route of Administration
7.14.5. By Distribution Channel
7.15.Key Representative Market Participants
7.16.Market Presence (Intensity Map)
8. Asia Pacific excluding Japan Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in China, India, Australia and New Zealand, ASEAN, and rest of Asia Pacific
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of Asia Pacific
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of Asia Pacific
8.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
8.5.1.Anti-Infective
8.5.2.Parasiticides
8.5.2.1.Endo-parasiticides
8.5.2.2.Ecto-parasiticides
8.5.2.3.Endectocides
8.5.3.Anti-inflammatory
8.5.4.Anesthetics
8.5.5.Analgesics
8.5.6.Hormones and related product
8.5.7.Others
8.6. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
8.6.1.Anti-Infective
8.6.2.Parasiticides
8.6.2.1.Endo-parasiticides
8.6.2.2.Ecto-parasiticides
8.6.2.3.Endectocides
8.6.3.Anti-inflammatory
8.6.4.Anesthetics
8.6.5.Analgesics
8.6.6.Hormones and related product
8.6.7.Others
8.7. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
8.7.1.Livestock Animals
8.7.1.1.Ruminants
8.7.1.2.Swine
8.7.1.3.Poultry
8.7.2.Equine
8.8. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
8.8.1.Livestock Animals
8.8.1.1.Ruminants
8.8.1.2.Swine
8.8.1.3.Poultry
8.8.2.Equine
8.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
8.9.1.Oral
8.9.2.Parenteral
8.9.3.Topical
8.9.4.Others
8.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
8.10.1. Oral
8.10.2. Parenteral
8.10.3. Topical
8.10.4. Others
8.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
8.11.1. Veterinary Hospitals
8.11.2. Veterinary Clinics
8.11.3. Pharmacies and Drug Stores
8.11.4. Others
8.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
8.12.1. Veterinary Hospitals
8.12.2. Veterinary Clinics
8.12.3. Pharmacies and Drug Stores
8.12.4. Others
8.13.Drivers and Restraints: Impact Analysis
8.14.Market Attractiveness Analysis
8.14.1. By Country
8.14.2. By Product Type
8.14.3. By Animal Type
8.14.4. By Route of Administration
8.14.5. By Distribution Channel
8.15.Key Representative Market Participants
8.16.Market Presence (Intensity Map)
9. Japan Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in Japan
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
9.3.1.Anti-Infective
9.3.2.Parasiticides
9.3.2.1.Endo-parasiticides
9.3.2.2.Ecto-parasiticides
9.3.2.3.Endectocides
9.3.3.Anti-inflammatory
9.3.4.Anesthetics
9.3.5.Analgesics
9.3.6.Hormones and related product
9.3.7.Others
9.4. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
9.4.1.Anti-Infective
9.4.2.Parasiticides
9.4.2.1.Endo-parasiticides
9.4.2.2.Ecto-parasiticides
9.4.2.3.Endectocides
9.4.3.Anti-inflammatory
9.4.4.Anesthetics
9.4.5.Analgesics
9.4.6.Hormones and related product
9.4.7.Others
9.5. Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
9.5.1.Livestock Animals
9.5.1.1.Ruminants
9.5.1.2.Swine
9.5.1.3.Poultry
9.5.2.Equine
9.6. Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
9.6.1.Livestock Animals
9.6.1.1.Ruminants
9.6.1.2.Swine
9.6.1.3.Poultry
9.6.2.Equine
9.7. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
9.7.1.Oral
9.7.2.Parenteral
9.7.3.Topical
9.7.4.Others
9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
9.8.1.Oral
9.8.2.Parenteral
9.8.3.Topical
9.8.4.Others
9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
9.9.1.Veterinary Hospitals
9.9.2.Veterinary Clinics
9.9.3.Pharmacies and Drug Stores
9.9.4.Others
9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
9.10.1. Veterinary Hospitals
9.10.2. Veterinary Clinics
9.10.3. Pharmacies and Drug Stores
9.10.4. Others
9.11.Drivers and Restraints: Impact Analysis
9.12.Market Attractiveness Analysis
9.12.1. By Product Type
9.12.2. By Animal Type
9.12.3. By Route of Administration
9.12.4. By Distribution Channel
9.13.Key Representative Market Participants
9.14.Market Presence (Intensity Map)
10. Middle East & Africa Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
Market forecast and analysis in South Africa, GCC Countries and rest of MEA
10.1.Introduction
10.2.Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3.Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
10.3.1. South Africa
10.3.2. GCC Countries
10.3.3. Rest of MEA
10.4.Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. South Africa
10.4.2. GCC Countries
10.4.3. Rest of MEA
10.5.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
10.5.1. Anti-Infective
10.5.2. Parasiticides
10.5.2.1. Endo-parasiticides
10.5.2.2. Ecto-parasiticides
10.5.2.3. Endectocides
10.5.3. Anti-inflammatory
10.5.4. Anesthetics
10.5.5. Analgesics
10.5.6. Hormones and related product
10.5.7. Others
10.6.Market Size (US$ Mn) Forecast By Product Type, 2017–2027
10.6.1. Anti-Infective
10.6.2. Parasiticides
10.6.2.1. Endo-parasiticides
10.6.2.2. Ecto-parasiticides
10.6.2.3. Endectocides
10.6.3. Anti-inflammatory
10.6.4. Anesthetics
10.6.5. Analgesics
10.6.6. Hormones and related product
10.6.7. Others
10.7.Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
10.7.1. Livestock Animals
10.7.1.1. Ruminants
10.7.1.2. Swine
10.7.1.3. Poultry
10.7.2. Equine
10.8.Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
10.8.1. Livestock Animals
10.8.1.1. Ruminants
10.8.1.2. Swine
10.8.1.3. Poultry
10.8.2. Equine
10.9.Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
10.9.1. Oral
10.9.2. Parenteral
10.9.3. Topical
10.9.4. Others
10.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
10.10.1. Oral
10.10.2. Parenteral
10.10.3. Topical
10.10.4. Others
10.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
10.11.1. Veterinary Hospitals
10.11.2. Veterinary Clinics
10.11.3. Pharmacies and Drug Stores
10.11.4. Others
10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
10.12.1. Veterinary Hospitals
10.12.2. Veterinary Clinics
10.12.3. Pharmacies and Drug Stores
10.12.4. Others
10.13. Drivers and Restraints: Impact Analysis
10.14. Market Attractiveness Analysis
10.14.1. By Country
10.14.2. By Product Type
10.14.3. By Animal Type
10.14.4. By Route of Administration
10.14.5. By Distribution Channel
10.15. Key Representative Market Participants
10.16. Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1.Market Structure
13.2.Market Share Analysis
13.3.Competition Dashboard
13.4.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.4.1. Bayer AG
13.4.2. Boehringer Ingelheim GmbH
13.4.3. Zoetis, Inc.
13.4.4. Ceva Santé Animale
13.4.5. Dechra Pharmaceuticals PLC
13.4.6. Elanco Animal Health (Sub. Eli Lilly)
13.4.7. Merck Animal Health
13.4.8. Virbac SA
13.4.9. Vetoquinol SA
13.4.10. Intas Animal Health
13.4.11. Alembic Animal Health
13.4.12. Sequent Scientific
13.4.13. Hester Biosciences
13.4.14. Ashish Life Sciences
13.4.15. Ouro Fino Saude Animal (Ourofino)
13.4.16. Zydus Animal Health (Sub. Cadila Healthcare Ltd)
13.4.17. Phibro Animal Health Corporation
13.4.18. Nippon Zenyaku Kogyo Co., Ltd
13.4.19. Norbrook
13.4.20. Kyoritsu Seiyaku Corporation
14. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027, By Region
A detailed, region-wise assessment, providing projections on market growth in key regions
14.1.Introduction/Key Findings
14.2.Historical Market Size (US$ Mn) Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Western Europe
14.2.3. Eastern Europe
14.2.4. Latin America
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3.Market Size (US$ Mn) Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Western Europe
14.3.3. Eastern Europe
14.3.4. Latin America
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4.Market Attractiveness Analysis By Region
15. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Classification by product type, highlighting historical trends, current market value, and future projections on the basis of key segments
15.1.Introduction/Key Findings
15.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
15.2.1. Anti-Infective
15.2.2. Parasiticides
15.2.2.1. Endo-parasiticides
15.2.2.2. Ecto-parasiticides
15.2.2.3. Endectocides
15.2.3. Anti-inflammatory
15.2.4. Anesthetics
15.2.5. Analgesics
15.2.6. Hormones and related product
15.2.7. Others
15.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2027
15.3.1. Anti-Infective
15.3.2. Parasiticides
15.3.2.1. Endo-parasiticides
15.3.2.2. Ecto-parasiticides
15.3.2.3. Endectocides
15.3.3. Anti-inflammatory
15.3.4. Anesthetics
15.3.5. Analgesics
15.3.6. Hormones and related product
15.3.7. Others
15.4.Market Attractiveness Analysis By Product Type
16. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027, By Animal Type
Classification based on animal type used in farm animal drugs
16.1.Introduction/Key Findings
16.2.Historical Market Size (US$ Mn) Analysis By Animal Type, 2012–2016
16.2.1. Livestock Animals
16.2.1.1. Ruminants
16.2.1.2. Swine
16.2.1.3. Poultry
16.2.2. Equine
16.3.Market Size (US$ Mn) Forecast By Animal Type, 2017–2027
16.3.1. Livestock Animals
16.3.1.1. Ruminants
16.3.1.2. Swine
16.3.1.3. Poultry
16.3.2. Equine
16.4.Market Attractiveness Analysis By Animal Type
17. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration
Route of administration currently gaining traction for farm animal drugs
17.1.Introduction/Key Findings
17.2.Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
17.2.1. Oral
17.2.2. Parenteral
17.2.3. Topical
17.2.4. Others
17.3.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
17.3.1. Oral
17.3.2. Parenteral
17.3.3. Topical
17.3.4. Others
17.4.Market Attractiveness Analysis By Route of Administration
18. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel
Distribution channel currently gaining traction for farm animal drugs
18.1.Introduction/Key Findings
18.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
18.2.1. Veterinary Hospitals
18.2.2. Veterinary Clinics
18.2.3. Pharmacies and Drug Stores
18.2.4. Others
18.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
18.3.1. Veterinary Hospitals
18.3.2. Veterinary Clinics
18.3.3. Pharmacies and Drug Stores
18.3.4.Others
18.4.Market Attractiveness Analysis By Distribution Channel
19. Global Farm Animal Drugs Market Analysis 2012–2016 and Forecast 2017–2027
19.1.Market Size and Y-o-Y Growth
19.2.Absolute $ Opportunity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report